Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellmann-Strobl

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Neurodegenerative Disease Management|November 10, 2020
Satralizumab in the treatment of neuromyelitis optica spectrum disorderAnkelien Duchow, Judith Bellmann-Strobl
Expert Opinion on Biological Therapy|April 2, 2020
Current and emerging biologics for the treatment of neuromyelitis optica spectrum disordersAnkelien Duchow, Friedemann Paul, Judith Bellmann-Strobl
Expert Opinion on Emerging Drugs|August 1, 2020
Emerging drugs for the treatment of neuromyelitis opticaAnkelien Duchow, Claudia Chien, Friedemann Paul, et al.
BMC Neurology|April 24, 2025
Isolated Uhthoff phenomenon as first manifestation of multiple sclerosis: a case reportAnnabelle Löffler, Charlotte Bereuter, Murat Delikaya, et al.
Acta Neurologica Belgica|November 13, 2020
Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosisJana Schließeit, Frederike Cosima Oertel, Graham Cooper, et al.
Expert Opinion on Biological Therapy|April 11, 2025
Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndromeFelix Wohlrab, Mailam Eltity, Friederike Ufer, et al.
Brain and Behavior|October 30, 2025
Neural Signatures of Flattened Emotional Experience in Patients With Early Multiple Sclerosis: A Bayesian ApproachTorsten Wüstenberg, René Gieß, Judith Bellmann-Strobl, et al.
Brain : a Journal of Neurology|October 23, 2003
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI studyJens Wuerfel, Judith Bellmann-Strobl, Peter Brunecker, et al.
Neurology|October 14, 2015
Iridodonesis as a cause of recurrent vertigoHagen Kunte, Friedemann Paul, Florence Pache, et al.
Multiple Sclerosis and Related Disorders|June 20, 2024
Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort studyPatrick Schindler, Judith Bellmann-Strobl, Jens Kuhle, et al.
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Neurodegenerative Disease Management|November 10, 2020
Satralizumab in the treatment of neuromyelitis optica spectrum disorderAnkelien Duchow, Judith Bellmann-Strobl
Expert Opinion on Biological Therapy|April 2, 2020
Current and emerging biologics for the treatment of neuromyelitis optica spectrum disordersAnkelien Duchow, Friedemann Paul, Judith Bellmann-Strobl
Expert Opinion on Emerging Drugs|August 1, 2020
Emerging drugs for the treatment of neuromyelitis opticaAnkelien Duchow, Claudia Chien, Friedemann Paul, et al.
BMC Neurology|April 24, 2025
Isolated Uhthoff phenomenon as first manifestation of multiple sclerosis: a case reportAnnabelle Löffler, Charlotte Bereuter, Murat Delikaya, et al.
Acta Neurologica Belgica|November 13, 2020
Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosisJana Schließeit, Frederike Cosima Oertel, Graham Cooper, et al.
Expert Opinion on Biological Therapy|April 11, 2025
Autoantibody targeting therapies in post COVID syndrome and myalgic encephalomyelitis/chronic fatigue syndromeFelix Wohlrab, Mailam Eltity, Friederike Ufer, et al.
Brain and Behavior|October 30, 2025
Neural Signatures of Flattened Emotional Experience in Patients With Early Multiple Sclerosis: A Bayesian ApproachTorsten Wüstenberg, René Gieß, Judith Bellmann-Strobl, et al.
Brain : a Journal of Neurology|October 23, 2003
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI studyJens Wuerfel, Judith Bellmann-Strobl, Peter Brunecker, et al.
Neurology|October 14, 2015
Iridodonesis as a cause of recurrent vertigoHagen Kunte, Friedemann Paul, Florence Pache, et al.
Multiple Sclerosis and Related Disorders|June 20, 2024
Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort studyPatrick Schindler, Judith Bellmann-Strobl, Jens Kuhle, et al.
Pageof 18